StockData
BillionToOne, Inc. logo

BillionToOne, Inc. (BLLN) stock

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$97.50+1.19 (+1.24%)

Close on Nov 17, 2026Market cap $4.60BP/E –Yield –

BillionToOne price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BillionToOne's price to sales ratio was 11.3× on Nov 11, 2026, against 5.7× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202611.3×+7.7
2025Dec 31, 20253.6×–

More BillionToOne figures

See a number that looks wrong?